A randomised trial to compare dolutegravir plus boosted darunavir versus recommended standard of care antiretroviral regimens in people with HIV-1, whose first-line non … - DARA

A randomised trial to compare dolutegravir plus boosted darunavir versus recommended standard of care antiretroviral regimens in people with HIV-1, whose first-line non …

Penulis: PP Nyein, M Borok, N Eriobu, R Kaplan, N Kumarasamy

Informasi

PenerbitClinical Infectious Diseases, ciaf346, 2025

Tahun Publikasi2025

Jenis SumberGoogle Scholar

Sitasi

Google Scholar: 1

Dokumen & Tautan